Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial

We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet inte...

Full description

Bibliographic Details
Main Authors: Álvaro Hernáez, Camille Lassale, Sara Castro-Barquero, Nancy Babio, Emilio Ros, Olga Castañer, Anna Tresserra-Rimbau, Xavier Pintó, Miguel Ángel Martínez-González, Dolores Corella, Jordi Salas-Salvadó, Ángel M. Alonso-Gómez, José Lapetra, Miquel Fiol, Enrique Gómez-Gracia, Lluis Serra-Majem, Emilio Sacanella, Ana García-Arellano, José V. Sorlí, Andrés Díaz-López, Montserrat Cofán, Ramón Estruch
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Foods
Subjects:
Online Access:https://www.mdpi.com/2304-8158/10/6/1268
id doaj-dd63f85cdfbd41658e509ec8388df346
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Álvaro Hernáez
Camille Lassale
Sara Castro-Barquero
Nancy Babio
Emilio Ros
Olga Castañer
Anna Tresserra-Rimbau
Xavier Pintó
Miguel Ángel Martínez-González
Dolores Corella
Jordi Salas-Salvadó
Ángel M. Alonso-Gómez
José Lapetra
Miquel Fiol
Enrique Gómez-Gracia
Lluis Serra-Majem
Emilio Sacanella
Ana García-Arellano
José V. Sorlí
Andrés Díaz-López
Montserrat Cofán
Ramón Estruch
spellingShingle Álvaro Hernáez
Camille Lassale
Sara Castro-Barquero
Nancy Babio
Emilio Ros
Olga Castañer
Anna Tresserra-Rimbau
Xavier Pintó
Miguel Ángel Martínez-González
Dolores Corella
Jordi Salas-Salvadó
Ángel M. Alonso-Gómez
José Lapetra
Miquel Fiol
Enrique Gómez-Gracia
Lluis Serra-Majem
Emilio Sacanella
Ana García-Arellano
José V. Sorlí
Andrés Díaz-López
Montserrat Cofán
Ramón Estruch
Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
Foods
white blood cell count
Mediterranean diet
leukopenia
leukocytosis
randomized controlled trial
prevention
author_facet Álvaro Hernáez
Camille Lassale
Sara Castro-Barquero
Nancy Babio
Emilio Ros
Olga Castañer
Anna Tresserra-Rimbau
Xavier Pintó
Miguel Ángel Martínez-González
Dolores Corella
Jordi Salas-Salvadó
Ángel M. Alonso-Gómez
José Lapetra
Miquel Fiol
Enrique Gómez-Gracia
Lluis Serra-Majem
Emilio Sacanella
Ana García-Arellano
José V. Sorlí
Andrés Díaz-López
Montserrat Cofán
Ramón Estruch
author_sort Álvaro Hernáez
title Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
title_short Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
title_full Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
title_fullStr Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
title_full_unstemmed Mediterranean Diet and White Blood Cell Count—A Randomized Controlled Trial
title_sort mediterranean diet and white blood cell count—a randomized controlled trial
publisher MDPI AG
series Foods
issn 2304-8158
publishDate 2021-06-01
description We aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 10<sup>9</sup> leukocytes/L), mild leukopenia (<4.5 × 10<sup>9</sup> leukocytes/L), or severe leukopenia (<3.5 × 10<sup>9</sup> leukocytes/L) in individuals without the condition at baseline (<i>n</i> = 3190, <i>n</i> = 2925, and <i>n</i> = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HR<sub>Q4-Q1</sub>: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (<i>P</i>-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals.
topic white blood cell count
Mediterranean diet
leukopenia
leukocytosis
randomized controlled trial
prevention
url https://www.mdpi.com/2304-8158/10/6/1268
work_keys_str_mv AT alvarohernaez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT camillelassale mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT saracastrobarquero mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT nancybabio mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT emilioros mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT olgacastaner mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT annatresserrarimbau mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT xavierpinto mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT miguelangelmartinezgonzalez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT dolorescorella mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT jordisalassalvado mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT angelmalonsogomez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT joselapetra mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT miquelfiol mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT enriquegomezgracia mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT lluisserramajem mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT emiliosacanella mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT anagarciaarellano mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT josevsorli mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT andresdiazlopez mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT montserratcofan mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
AT ramonestruch mediterraneandietandwhitebloodcellcountarandomizedcontrolledtrial
_version_ 1721352166708346880
spelling doaj-dd63f85cdfbd41658e509ec8388df3462021-06-30T23:08:03ZengMDPI AGFoods2304-81582021-06-01101268126810.3390/foods10061268Mediterranean Diet and White Blood Cell Count—A Randomized Controlled TrialÁlvaro Hernáez0Camille Lassale1Sara Castro-Barquero2Nancy Babio3Emilio Ros4Olga Castañer5Anna Tresserra-Rimbau6Xavier Pintó7Miguel Ángel Martínez-González8Dolores Corella9Jordi Salas-Salvadó10Ángel M. Alonso-Gómez11José Lapetra12Miquel Fiol13Enrique Gómez-Gracia14Lluis Serra-Majem15Emilio Sacanella16Ana García-Arellano17José V. Sorlí18Andrés Díaz-López19Montserrat Cofán20Ramón Estruch21August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainDepartment of Preventive Medicine and Public Health, Universidad de Málaga, 29071 Málaga, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainConsorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainAugust Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, SpainWe aimed to assess the effects of the antioxidant-rich Mediterranean diet (MedDiet) on white blood cell count. Our study population included participants in the PREvención con DIeta MEDiterránea study (average age 67 years old, 58% women, high cardiovascular risk). We assessed whether a MedDiet intervention enriched in extra-virgin olive oil or nuts, versus a low-fat control diet, modified the incidence of leukocytosis (>11 × 10<sup>9</sup> leukocytes/L), mild leukopenia (<4.5 × 10<sup>9</sup> leukocytes/L), or severe leukopenia (<3.5 × 10<sup>9</sup> leukocytes/L) in individuals without the condition at baseline (<i>n</i> = 3190, <i>n</i> = 2925, and <i>n</i> = 3190, respectively). We also examined whether MedDiet modified the association between leukocyte count alterations and all-cause mortality. Both MedDiet interventions were associated with a lower risk of developing leukopenia (incidence rates: 5.06% in control diet, 3.29% in MedDiet groups combined; hazard ratio [95% confidence interval]: 0.54 [0.36–0.80]) and severe leukopenia (incidence rates: 1.26% in control diet, 0.46% in MedDiet groups combined; hazard ratio: 0.25 [0.10–0.60]). High cumulative adherence to a MedDiet was linked to lower risk of leukocytosis (incidence rates: 2.08% in quartile 1, 0.65% in quartile 4; HR<sub>Q4-Q1</sub>: 0.29 [0.085–0.99]) and attenuated the association between leukopenia and all-cause mortality (<i>P</i>-interaction = 0.032). In brief, MedDiet decreased the incidence of white blood cell count-related alterations in high cardiovascular risk individuals.https://www.mdpi.com/2304-8158/10/6/1268white blood cell countMediterranean dietleukopenialeukocytosisrandomized controlled trialprevention